Michael Liptay to Radiopharmaceuticals
This is a "connection" page, showing publications Michael Liptay has written about Radiopharmaceuticals.
Connection Strength
1.514
-
Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial. J Thorac Oncol. 2009 Feb; 4(2):198-202.
Score: 0.323
-
Sentinel node mapping in lung cancer: the Holy Grail? Ann Thorac Surg. 2008 Feb; 85(2):S778-9.
Score: 0.302
-
Sentinel lymph node mapping in lung cancer. Cancer Treat Res. 2005; 127:141-50.
Score: 0.244
-
Commentary on sentinel lymph node identification with technetium-99m tin colloid in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002 Sep; 124(3):428-30.
Score: 0.207
-
Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastases. J Clin Oncol. 2002 Apr 15; 20(8):1984-8.
Score: 0.202
-
Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg. 2000 Aug; 70(2):384-9; discussion 389-90.
Score: 0.179
-
Sentinel node mapping in lung cancer. Ann Surg Oncol. 2004 Mar; 11(3 Suppl):271S-4S.
Score: 0.057